BackPyxis Oncology Overview

Pyxis Oncology Current Cash

Track Pyxis Oncology's current cash ($7.2M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$7.24M
43.27% YoYΔ $-5.52M vs prior year quarter

Peer average

Loading

Pyxis Oncology Current Cash History

Loading

Pyxis Oncology vs. peers: Current Cash Comparison

Loading

Pyxis Oncology Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pyxis Oncology (PYXS) FAQ

As of the most recent data (March 2026), PYXS shows a current cash of $7.2M. That compares with $13M in the prior-year period — down 43.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PYXS's current cash is now $7.2M (was $13M) — a 43.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pyxis Oncology is outperforming or lagging.

Tracking PYXS's current cash over time shows whether Pyxis Oncology is scaling, shrinking, or reshaping that part of the business. The current reading is $7.2M That compares with $13M in the prior-year period — down 43.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Pyxis Oncology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $7.2M) with ownership activity and broader fundamentals.

Pyxis Oncology's current cash is $7.2M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.